Store-operated Ca2+ entry is not essential for PDGF-BB induced phenotype modulation in rat aortic smooth muscle

Cell Calcium

Volumn 48, Issue 1, 2010, Pages 10-18

  Emter, Craig A ^a   Bowles, Douglas K ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Phenotype modulation; Smooth muscle

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BROMOENOL LACTONE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MYOCARDIN; MYOSIN; PLATELET DERIVED GROWTH FACTOR BB; SMOOTHELIN;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; MARKER GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

RATTUS;

EID: 77956012217     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2010.06.001     Document Type: Article

References (55)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., Hailpern S.M., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C., Roger V., Sorlie P., Steinberger J., Thom T., Wilson M., Hong Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-146.
2. Camenzind E. Treatment of in-stent restenosis-back to the future?. N. Engl. J. Med. 2006, 355:2149-2151.
3. Scheller B., Hehrlein C., Bocksch W., Rutsch W., Haghi D., Dietz U., Bohm M., Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med. 2006, 355:2113-2124.
4. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
5. Wamhoff B.R., Bowles D.K., Owens G.K. Excitation-transcription coupling in arterial smooth muscle. Circ. Res. 2006, 98:868-878.
6. + channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H2493-H2503.
7. Kohler R., Wulff H., Eichler I., Kneifel M., Neumann D., Knorr A., Grgic I., Kampfe D., Si H., Wibawa J., Real R., Borner K., Brakemeier S., Orzechowski H.D., Reusch H.P., Paul M., Chandy K.G., Hoyer J. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003, 108:1119-1125.
8. Tharp D.L., Wamhoff B.R., Wulff H., Raman G., Cheong A., Bowles D.K. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1084-1089.
9. Toyama K., Wulff H., Chandy K.G., Azam P., Raman G., Saito T., Fujiwara Y., Mattson D.L., Das S., Melvin J.E., Pratt P.F., Hatoum O.A., Gutterman D.D., Harder D.R., Miura H. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J. Clin. Invest. 2008.
10. 2+ entry in human pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1233-L1245.
11. Golovina V.A. Cell proliferation is associated with enhanced capacitative Ca(2+) entry in human arterial myocytes. Am. J. Physiol. 1999, 277:C343-C349.
12. Golovina V.A., Platoshyn O., Bailey C.L., Wang J., Limsuwan A., Sweeney M., Rubin L.J., Yuan J.X. Upregulated TRP and enhanced capacitative Ca(2+) entry in human pulmonary artery myocytes during proliferation. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H746-H755.
13. Lu K.P., Means A.R. Regulation of the cell cycle by calcium and calmodulin. Endocr. Rev. 1993, 14:40-58.
14. Parekh A.B., Penner R. Store depletion and calcium influx. Physiol. Rev. 1997, 77:901-930.
15. Parekh A.B., Putney J.W. Store-operated calcium channels. Physiol. Rev. 2005, 85:757-810.
16. Parekh A.B. Store-operated channels: mechanisms and function. J. Physiol. 2008, 586:3033.
17. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 283:L144-L155.
18. Yu Y., Sweeney M., Zhang S., Platoshyn O., Landsberg J., Rothman A., Yuan J.X. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am. J. Physiol. Cell. Physiol. 2003, 284:C316-C330.
19. Kumar B., Dreja K., Shah S.S., Cheong A., Xu S.Z., Sukumar P., Naylor J., Forte A., Cipollaro M., McHugh D., Kingston P.A., Heagerty A.M., Munsch C.M., Bergdahl A., Hultgardh-Nilsson A., Gomez M.F., Porter K.E., Hellstrand P., Beech D.J. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ. Res. 2006, 98:557-563.
20. 2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ. Res. 2004, 95:406-414.
21. 2+ source-dependent transcription of CRE-containing genes in vascular smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H97-105.
22. 2+ entry activates the CREB transcription factor in vascular smooth muscle. Circ. Res. 2004, 94:1351-1358.
23. Morales S., Diez A., Puyet A., Camello P.J., Camello-Almaraz C., Bautista J.M., Pozo M.J. Calcium controls smooth muscle TRPC gene transcription via the CaMK/calcineurin-dependent pathways. Am. J. Physiol. Cell. Physiol. 2007, 292:C553-C563.
24. Kawai-Kowase K., Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 2007, 292:C59-69.
25. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 1995, 75:487-517.
26. Flemming R., Xu S.Z., Beech D.J. Pharmacological profile of store-operated channels in cerebral arteriolar smooth muscle cells. Br. J. Pharmacol. 2003, 139:955-965.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
28. Balsinde J., Dennis E.A. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J. Biol. Chem. 1996, 271:31937-31941.
29. Nanjundan M., Possmayer F. Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284:L1-23.
30. Winstead M.V., Balsinde J., Dennis E.A. Calcium-independent phospholipase A(2): structure and function. Biochim. Biophys. Acta 2000, 1488:28-39.
31. Kondo T., Konishi F., Inui H., Inagami T. Differing signal transductions elicited by three isoforms of platelet-derived growth factor in vascular smooth muscle cells. J. Biol. Chem. 1993, 268:4458-4464.
32. 2+-channel blockers inhibit the action of recombinant platelet-derived growth factor in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:2388-2392.
33. Matsunaga H., Ling B.N., Eaton D.C. Ca(2+)-permeable channel associated with platelet-derived growth factor receptor in mesangial cells. Am. J. Physiol. 1994, 267:C456-C465.
34. Blank R.S., Owens G.K. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J. Cell. Physiol. 1990, 142:635-642.
35. Corjay M.H., Blank R.S., Owens G.K. Platelet-derived growth factor-induced destabilization of smooth muscle alpha-actin mRNA. J. Cell. Physiol. 1990, 145:391-397.
36. Dandre F., Owens G.K. Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H2042-H2051.
37. Van Putten V., Li X., Maselli J., Nemenoff R.A. Regulation of smooth muscle alpha-actin promoter by vasopressin and platelet-derived growth factor in rat aortic vascular smooth muscle cells. Circ. Res. 1994, 75:1126-1130.
38. 2+ entry. J. Biol. Chem. 2003, 278:11909-11915.
39. Smani T., Zakharov S.I., Csutora P., Leno E., Trepakova E.S., Bolotina V.M. A novel mechanism for the store-operated calcium influx pathway. Nat. Cell Biol. 2004, 6:113-120.
40. Singaravelu K., Lohr C., Deitmer J.W. Regulation of store-operated calcium entry by calcium-independent phospholipase A2 in rat cerebellar astrocytes. J. Neurosci. 2006, 26:9579-9592.
41. 2+-independent phospholipase A2 and store-operated pathway in urocortin-induced vasodilatation of rat coronary artery. Circ. Res. 2007, 101:1194-1203.
42. 2+-entry pathway. Trends Biochem. Sci. 2005, 30:378-387.
43. Bolotina V.M. Orai, STIM1 and iPLA2beta: a view from a different perspective. J. Physiol. 2008, 586:3035-3042.
44. 2+-independent phospholipase A2beta-mediated pathway. J. Biol. Chem. 2006, 281:34926-34935.
45. Csutora P., Peter K., Kilic H., Park K.M., Zarayskiy V., Gwozdz T., Bolotina V.M. Novel role for STIM1 as a trigger for calcium influx factor production. J. Biol. Chem. 2008, 283:14524-14531.
46. 2+ influx and constriction in cerebral, mesenteric, and carotid arteries. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H1183-H1187.
47. Barrett T.B, Benditt E.P. sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:1099-1103.
48. Holycross B.J., Blank R.S., Thompson M.M., Peach M.J., Owens G.K. Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ. Res. 1992, 71:1525-1532.
49. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., Clowes A.W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 1992, 89:507-511.
50. Wamhoff B.R., Hoofnagle M.H., Burns A., Sinha S., McDonald O.G., Owens G.K. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ. Res. 2004, 95:981-988.
51. Pipes G.C., Creemers E.E., Olson E.N. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006, 20:1545-1556.
52. Touyz R.M, Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 2000, 52:639-672.
53. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 2002, 82:131-185.
54. Ghanshani S., Wulff H., Miller M.J., Rohm H., Neben A., Gutman G.A., Cahalan M.D., Chandy K.G. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem. 2000, 275:37137-37149.
55. + channels in postischaemic heart. Clin. Exp. Pharmacol. Physiol. 2002, 29:324-329.